by Scott Larrivee | Nov 6, 2025 | Blog
Nov. 6, 2025 – Nusano CEO, Chris Lowe, is the featured guest on the new edition of the Healthcare Technology Report podcast with RJ Lumba. The two discuss: Nusano’s breakthrough radioisotope production platform; The company’s endeavors beyond life...
by Scott Larrivee | Nov 6, 2025 | Blog, Utah
SALT LAKE CITY – Nov. 5, 2025 – Nusano is honored to receive the 2025 Innovation Impact Award from BioUtah. The award recognizes organizations making an indelible mark on Utah’s life sciences community. BioUtah writes: “We are proud to recognize this...
by Scott Larrivee | Oct 16, 2025 | News
The following is a copy of a press release issued by Clarity Pharmaceuticals Sydney, Australia 16 October 2025 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products...
by Scott Larrivee | Oct 14, 2025 | Utah
SALT LAKE CITY – October 14, 2025 – Nusano radiochemist Lauren Radford has been named a “Healthcare Hero” by Utah Business. Utah Business’s annual Healthcare Heroes Awards honor individuals making a significant impact in the fields of healthcare,...
by Scott Larrivee | Oct 14, 2025 | News
Agreement includes Actinium-225 (Ac-225) and Lutetium-177 (Lu-177) to support Ariceum’s therapeutic programs WEST VALLEY CITY, Utah and BERLIN, Germany – Oct. 14, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Ariceum Therapeutics...
